ERBB2 and invasive breast carcinoma: We have used KMplotter (23) to analyze survival correlations of gene expression of CDK8, CDK19, and their binding partner CCNC using microarray data from 846 BrCa patients that were negative for ER and HER2 (an approximation of TNBC).